Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
about
P1343
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancerEstablishment of a human hepatoma multidrug resistant cell line in vitroReduced nuclear binding of a DNA minor groove ligand (Hoechst 33342) and its impact on cytotoxicity in drug resistant murine cell linesInteractions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranesMolecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells.Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer.Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionMultidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines.Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistanceDevelopment of drug resistance in a human epidermoid lung carcinoma xenograft lineCross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line.In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance.The clinical relevance of multidrug resistance.Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer.The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues.Proteomic approaches for investigation of therapy resistance in cancer.Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compoundscGMP and glutathione-conjugate transport in human erythrocytes.Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell lineMultidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon.Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitroDifferential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.The use of clonogenic assays in assessing the response of human lung cancer cell lines to alpha and gamma interferons alone or in combination with adriamycin.Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line.Isolation and characterization of an adriamycin-resistant breast tumor cell line.Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporinsIncreased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.Oncogene amplification and chromosomal abnormalities in small cell lung cancer.Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69.Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.Multiparametric analysis of cell membrane permeability by two colour flow cytometry with complementary fluorescent probes
P2860
Q28378751-7B9935F4-504F-48EE-9E2E-138DF4209375Q33574625-4D463053-4D83-46C2-A4BE-1E5A096A437CQ34263868-BFE37D25-9F5C-4BD9-B67A-E70B42B2B961Q34325960-86A6AB1B-F6B5-4E41-9EDA-678D67539141Q34996536-C39AA25B-505F-4F7E-9AB2-823633FD890AQ35158232-E57DB118-104D-4264-9951-E21132C26D1FQ35983304-2F8712C0-91AB-49B8-BFE0-9743130AA83DQ35992775-77D8C89E-356A-4865-B58C-7080889DA901Q36079602-48802763-B457-40FD-97AF-6D4D7AC8621FQ36135196-E6B411CD-F42D-4096-9DE5-697B608B9F6CQ36466011-4DA24D9C-286B-4545-8E22-4370EF914BEEQ36466678-781943FA-57B5-4535-9C6E-3269020291DDQ36467852-9F7D8E22-351D-4C5E-81A2-94E451A50F2BQ36619418-802B6167-ECA6-40B3-BA99-772C5C0C0824Q37607274-29535299-8BF2-428E-AA27-35731374C223Q39223532-CFCBE6C3-9E34-482B-91AB-F0D1EBC9ABD8Q39693736-88317157-D3CD-43DD-B595-0078A519BED5Q39959305-C1F1E212-2BB0-4424-B2A8-04661251E72BQ40001475-29A50C69-CD14-4955-A6E3-6E58FEC548DBQ40638778-35848BEF-5C86-4AB0-8815-513C0C13D096Q41147831-69446E50-0BA0-45F1-8303-87F49CDFEC44Q41204990-31313585-F1E7-42BA-81D1-E809F0A5D6DEQ41331081-E86911E3-2D04-43CC-914A-FEF99A02A8C2Q41361539-C8C71981-01CB-40F1-B5E4-6115EC257CF8Q41459272-831F1419-C9E5-4117-B220-8ADD1FB837DDQ41638529-29A570BD-121D-4B3E-A7E0-315C03FC332DQ41642445-FAD2C63A-ED36-4716-8EF3-1782D4BFCDCFQ41721618-260EE66D-775D-4718-88B0-27A65BB1EA1AQ41733202-F24B6EBC-6AF2-4696-86D1-895162FCFD57Q41733228-B0CEEB8C-252C-438B-A4F3-8492A03C80BAQ41812714-2DC27B9E-38A8-4D37-BF5F-2E036EC3BEEBQ41972709-E323840D-10AD-420B-A247-3C336F63CC3FQ42373010-38E883E4-7980-4C9B-B182-D426B5184E58Q42820157-782209BE-DB44-4422-B1E7-07F1320650F3Q43050121-8B1C300B-AF86-41A1-996D-76535619B55BQ43051151-4226AF8E-43F0-46E3-9138-3865D57D3FADQ50892060-A1508842-98CF-4A1A-B96F-045629612549Q54386976-35BF7980-4640-46DE-B415-AA7E8EA6C928Q58283141-3D45A7F5-6490-42EE-9C39-BED11EFA0F7D
P2860
Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Derivation and preliminary cha ...... es of human lung cancer cells.
@ast
Derivation and preliminary cha ...... es of human lung cancer cells.
@en
type
label
Derivation and preliminary cha ...... es of human lung cancer cells.
@ast
Derivation and preliminary cha ...... es of human lung cancer cells.
@en
prefLabel
Derivation and preliminary cha ...... es of human lung cancer cells.
@ast
Derivation and preliminary cha ...... es of human lung cancer cells.
@en
P2093
P2860
P356
P1476
Derivation and preliminary cha ...... es of human lung cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1986.83
P407
P4510
P577
1986-04-01T00:00:00Z